openPR Logo
Press release

Chronic Disease Management Market Research Report - Forecast to 2027

12-27-2017 03:14 PM CET | Health & Medicine

Press release from: Market Research Future

Chronic Disease Management Market

Chronic Disease Management Market

There is huge market for chronic diseases management globally owing to its application in various field such as such as diabetes, cardiovascular diseases, cancer, autoimmune diseases, chronic obstructive pulmonary disorder, and few others. Increasing prevalence of chronic disease globally considering the major factor which lead the growth of chronic diseases management market globally. According to Cancer research UK, in 2014, around 356,860 people were diagnosed with cancer. Report suggest that it incident of cancer are rising rapidly in last few years and expected to grow quickly in coming future owing to unhealthy diets, high rate of smoke and alcohol consumption.

Get a sample report at https://www.marketresearchfuture.com/sample_request/981 .

Chronic disease management service is taking gaining the attractiveness throughout the globe, due to the use of health information technologies and improved availability of the online resource in the healthcare. Approximately 36 million patients took advantage of Medicare reimbursement policy in 2015 due to chronic disease management services. There is huge competition among the leading services provider in this market. Both leading and local service provider offers various scheme to compete in the market.
According to a recent study published by the Market Research Future analysts, the global chronic disease management market is a dynamic market growing at double digit growth rate. The growth of this market is mainly due to rise in the prevalence of the chronic diseases. Increase in prevalence has led to the high demand for the chronic care devices, tools, and monitoring software. Moreover, increasing investment in Research and development, and availability of funds drive the growth of the market. Moreover, increasing government support, changing lifestyle, and rapidly developing technology is expected to fuel the market growth.
On the other hand, there are some hurdles in this market such as high cost involved in the development of the required infrastructure. Moreover, there is poor patient engagement, lack of interoperability, and concerns about the data security which can hinder the growth of the chronic disease management market to an extent.

Global Chronic Disease Management Market - Competitive Analysis
The global market consist of players such as TriZetto Corporation (U.S.), Phytel Inc (U.S.), Pegasystems Inc. (U.S.), AxisPoint Health (U.S.), Wellcentive, Inc, Medecision, Inc (U.S.), i2i Systems, Inc (U.S.), HealthSmart Holdings, Inc (U.S.), Allscripts Healthcare Solutions, Inc. (U.S.), ZeOmega Inc. (U.S.), Epic Systems Corporation (U.S.), ScienceSoft USA Corporation (U.S.) Harmony Information Systems, Inc. (U.S.), Infosys Limited (India), and others. These are some of the prominent players at the forefront of competition in the global chronic disease management market.
The market for chronic disease management, although being a relatively nascent market, has good number of companies operating in this market. There are number of companies involved in the development of the products, including the devices, tools, software, web portals, and other services in the chronic disease management space. Product launches, software update launches, and mergers & acquisitions are some key strategies of the companies in this market. Some of the developments for players are as follows.

Browse Complete Report at https://www.marketresearchfuture.com/reports/chronic-diseases-management-market-981 .

In September 2017, Sciencesoft released Version 3.0.0 Health CheckFramework (HCF) for IBM QRadar SIEM
In October 2016, Pegasystems Inc. the software company empowering customer engagement, announced a partnership with MCG Health, the leader in evidence-based care guidelines. The major goal from this partnerships is to enhance the care experience for patients with chronic conditions while enabling care management teams to achieve better patient outcomes.
Global Chronic Disease Management Market - Regional Analysis
The Americas region dominate the global chronic diseases management market owing to the presence of huge patient population with chronic diseases, and increasing government support for research & development. Furthermore, presence of large number of market players in this region which are involved in continuous development of the quality products which cater to the global patient population giving an extra boost for the growth of this market in Americas region.
Europe accounts for the second largest share of the global chronic diseases management market as result of increasing focus of government agencies on the treatment of chronic diseases. Moreover, the growing public awareness about chronic diseases management likely to boost the European market. Asia Pacific region is not far behind & is currently the fastest growing market in the chronic diseases management business space. Japan holds the major share of the regional market due to availability of advanced technology and huge healthcare spending. Moreover, rapidly developing economy, increasing healthcare expenditure, and the government’s initiatives for research & development projected to drive the market in China and India over the forecast period.

More Inquire at https://www.marketresearchfuture.com/enquiry/981 .

The Middle East and Africa contributes least in the global market due to limited availability of medical facilities, unavailability of the required infrastructure, affordability issues, and lack of awareness among masses. However, UAE, Saudi Arabia, and Kuwait are somehow the saving grace for the chronic disease management market in this region.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future
P: +1 646 845 9312
W: www.marketresearchfuture.com
sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chronic Disease Management Market Research Report - Forecast to 2027 here

News-ID: 877512 • Views:

More Releases from Market Research Future

Hydrofluoric Acid Market (CAGR) of 4%, Innovation Imperative Future Proofing Your Business with Market Size
Hydrofluoric Acid Market (CAGR) of 4%, Innovation Imperative Future Proofing You …
Hydrofluoric acid (HF) is a crucial chemical compound with a wide range of applications across various industries. Despite its hazardous nature, it plays an essential role in manufacturing processes, especially in the production of fluorine compounds. The global hydrofluoric acid market has been witnessing steady growth, driven by demand from end-user industries such as oil refining, pharmaceuticals, and electronics. The Hydrodesulfurization Catalysts Market is projected to register a CAGR of over
Palm Methyl Ester Derivative Market Size Projected to Grow at 5.92% CAGR, Reaching USD 2.4 billion by 2030
Palm Methyl Ester Derivative Market Size Projected to Grow at 5.92% CAGR, Reachi …
In recent years, the global market for palm methyl ester derivatives has witnessed significant growth, driven by various factors including environmental concerns, technological advancements, and the increasing demand for sustainable alternatives in various industries. Palm methyl ester derivatives, derived from palm oil, have emerged as versatile ingredients with applications spanning across sectors such as cosmetics, pharmaceuticals, lubricants, and more. The Palm Methyl Ester Derivative Market Size was valued at USD 1.5
Asia-Pacific Ceramic Tiles Market to Register Highest CAGR Growth of 7.50% by 2032: Analysis by Segmentation, Competitors Analysis
Asia-Pacific Ceramic Tiles Market to Register Highest CAGR Growth of 7.50% by 20 …
The Asia-Pacific ceramic tiles market has been witnessing robust growth, driven by various factors such as increasing investments in residential and commercial construction, renovation activities, and the growing preference for aesthetically pleasing and durable flooring solutions. Countries like China, India, Japan, and South Korea have been leading the market growth, supported by strong manufacturing capabilities, technological advancements, and evolving consumer preferences. Asia-Pacific Ceramic Tiles Market Size was valued at USD 141.2
APAC Wallpaper Market to Register Highest CAGR Growth of 8% by 2032: Analysis by Segmentation, Competitors Analysis
APAC Wallpaper Market to Register Highest CAGR Growth of 8% by 2032: Analysis by …
The APAC wallpaper market has witnessed significant growth in recent years, driven by factors such as rising disposable incomes, expanding construction activities, and growing awareness regarding interior decor. Countries like China, India, Japan, South Korea, and Australia have emerged as key contributors to the region's wallpaper market. Additionally, the increasing adoption of innovative wallpaper designs and patterns is fueling market growth further. APAC Wallpaper Market Size was valued at USD 0.55

All 5 Releases


More Releases for Chronic

Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Reviewed, …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017”, provides an overview of Chronic Kidney Disease (Chronic Renal Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Kidney Disease (Chronic Renal Failure). Report includes an overview of trial numbers and
Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Market Res …
Latest industry research report on: Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData's clinical trial report, Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Kidney Disease (Chronic Renal Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Kidney
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, T …
Orbisreserach.Com Adds “H1 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Market Pipeline Review 2017 Trend Analysis Report Report” To Its Research Database Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2017, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) pipeline landscape. Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a type of cancer that starts in the blood-forming cells of the
Boot chronic pain
For immediate release Due to our rushed lives and stressful environment, many people are suffering from chronic pain and fatigue. We feel permanently tired and are barely able to get through our normal day. One is able to change this status when following the guidelines the book "Tired of being Tired to the point of being Gatvol (Fed Up). Some people will need a team of medical practitioners to help them
11-10-2016 | Health & Medicine
MRR.biz
Global Chronic, Acute, And Neuropathic Pain Market: Opioids To Remain Most Value …
The research report, titled “Frontier Pharma: Chronic, Acute And Neuropathic Pain - GPCR And Nerve Growth Factor-Based Therapies Offer Strong Potential In Difficult-To-Treat Subtypes,” analyzes the historical as well as the existing performance of this market, emphasizing specifically on various types of therapies applied to treat chronic, acute, and neuropathic pain. According to this 68-page study, the worldwide market for chronic, acute, and neuropathic pain has been observing a significant
Targeting chronic pain
With the support of the Austrian Science Fund FWF, the neurophysiologist Ruth Drdla-Schutting is investigating the role astrocytes play in the genesis of chronic pain. With the help of innovative gene technology (DREADDs), scientists are tailoring treatment specifically to these cells that are the most numerous found in the central nervous system. Pain is an important protection system of the human body. But when it becomes chronic, as it frequently